At Lone Star Infusion, we specialize in Ketamine IV Infusion Treatments designed to help alleviate mental disorders such as depression, anxiety, PTSD, OCD, and bipolar disorder, as well as neuropathic pain conditions including CRPS/RSD, fibromyalgia, migraines, and other nerve-related pain symptoms.
Will My Insurance Cover My Ketamine Treatment?
The Answer: Unfortunately, at this time, most insurance providers do not cover Ketamine treatment. However, patients may be able to file a claim with their insurance company and potentially receive reimbursement for a portion of the office visit.
Alternative Payment Options
Funds from Flexible Spending Accounts (FSAs) or Health Savings Accounts (HSAs) may be used for ketamine treatments. Most employers require a statement detailing the services rendered. Please consult your FSA/HSA administrator to confirm eligibility.
Why Is Insurance Not Covering Ketamine Treatment?
Currently, Ketamine IV therapy is considered an off-label treatment, which makes it challenging to obtain FDA approval for widespread coverage. However, we encourage individuals to contact their insurance providers directly to inquire whether their policies will cover IV infusions.
If your insurance covers it, you’re in luck! If not, we recommend following these steps to potentially get a portion of the treatment reimbursed:
Steps to File a Claim and Seek Reimbursement:
- Call your insurance company and request a claim form.
- Obtain a Superbill from our office, which includes all necessary codes for completing the form.
-
- A letter from your doctor, psychiatrist, or therapist recommending Ketamine therapy.
- Research articles about the success of Ketamine treatments (we provide these on our website).
- A personal letter detailing your treatment history, including what has or hasn’t worked for you.Provide supporting documentation, which may include:
The Ketamine Task Force is actively working with lobbyists to increase awareness of the benefits of Ketamine therapy for mental illnesses and neuropathic pain. In addition, the American Medical Association is working to develop new codes for psychedelic therapies, which could pave the way for more insurance coverage in the future.
